Categories
Business Consultant

India’s GDP growth slips to 3.1% in Q4, stands at 11-yr low of 4.2% in FY20

The Indian overall economy grew at three.one for each cent in the January-March quarter (This fall) of 2020, its slowest speed in at minimum two a long time, as the coronavirus pandemic weakened the by now declining client demand and non-public investment, formal gross domestic product (GDP) facts produced on Friday showed. For the complete FY20 monetary calendar year, the headline quantity arrived to an 11-calendar year lower of 4.two for each cent, in opposition to 6.one for each cent in 2018-19.

The development numbers were being broadly in line with estimates by brokerages and economists, who have witnessed the

Read More
Categories
Business Value

HUL Q4 consolidated net profit slips 3.56% YoY to Rs 1,515 crore

Hindustan Unilever (HUL) on Thursday posted a 3.fifty six for each cent year-on-year (YoY) decline in its consolidated net financial gain at Rs 1,515 crore for the quarter finished March 2020. The company had posted financial gain of Rs 1,571 crore in the year-in the past period of time. On standalone foundation, numbers stood at Rs 1,519 crore, down 1.23 for each cent from Rs 1,538 crore in the corresponding quarter of the preceding fiscal.

Revenue from functions (on consolidated foundation) stood at Rs 9,055 crore, down almost 10 for each cent from Rs 10,018 crore in the year-in the

Read More
Categories
Business Value

MARKET LIVE: Sensex slips 150 pts; private banks weak, IRCTC surges 10%

Benchmark indices ended up investing lessen on Thursday as traders reassessed the scope of the coronavirus outbreak after China’s Hubei province reported a record increase in the demise toll. A .three for every cent contraction in factory output in December and the retail inflation rate hitting multi-yr large amount in January also dampened sentiment.

The S&P BSE Sensex dipped 160 points, or .four for every cent, to forty one,400 ranges. IndusInd Lender, HCL Tech (each down one%), and HIndustan Unilever (down .9 for every cent) ended up the major laggards in the Sensex pack. On the other hand, Condition Lender

Read More
Categories
Business Express

SPARC slips 10% as USFDA rejects cancer drug application

Enterprise Regular

The business has received a Total Reaction Letter (CRL) from the USFDA for the new drug software (NDA) for Taclantis (Paclitaxel Injection Focus for Suspension).


SI Reporter  | 
Mumbai 




medicine, drug, drugs, tablets

Image: Shutterstock

Shares of Sun Pharma Sophisticated Research Organization (SPARC) slipped ten for each cent to Rs 172 on the BSE on Wednesday in an usually strong current market following the US wellbeing regulator rejected the cancer drug software.

SPARC on Tuesday explained the business has received a Total Reaction Letter (CRL) from the United States Foodstuff & Drug Administration (USFDA)

Read More